GlassScriptPhysician profile
Zuyue Wang
NPI 1598719981
$12,523.16
in general payments reported to CMS, 2019-2025
17 companies · $1,959 in 2025
The $1,959 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,476 · 2020: $81.88 · 2021: $2,946 · 2022: $1,274 · 2023: $970 · 2024: $1,816 · 2025: $1,959.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,890 · Travel and Lodging: $1,856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,889.93 |
| Travel and Lodging | $1,855.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,950.97 | 2019-2025 | Mitraclip |
| Edwards Lifesciences Corporation | $3,102.72 | 2019-2025 | Sapien 3 Ultra Resilia, Pascal |
| Medtronic, INC. | $3,049.46 | 2021-2025 | Onyx Frontier, Apollotm |
| Artivion, INC. | $632.67 | 2023-2025 | Cardiac Non-Synergraft |
| Philips North America LLC | $502.36 | 2022-2024 | (9520) Igt Devices Undivided, (9148) Ice 3d |
| Boston Scientific Corporation | $347.05 | 2022-2023 | Watchman Access System |
| Ge Healthcare | $195.80 | 2022-2024 | |
| Abiomed | $192.20 | 2024-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $140.62 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $117.80 | 2024 | Magnetom Free.Max |
| Arineta, INC | $86.19 | 2022 | |
| Heartflow, INC. | $75.53 | 2022 | |
| Medtronic Vascular, INC. | $49.93 | 2019-2020 | |
| Biosense Webster, INC. | $23.92 | 2025 | Nuvision Ice Catheter |
| Amarin Pharma, INC. | $21.30 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $19.53 | 2024 | |
| Cleerly, INC. | $15.11 | 2023 | Cleerly Labs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zuyue Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.